Search
Searching with a thematic focus on WTO, Trade Policy, WTO Doha, Intellectual Property Rights
Showing 11-20 of 22 results
Pages
- Document
Post-Doha African challenges in the Sanitary and Phytosanitary and Trade Related Intellectual Property Rights Agreement
Kenya Institute for Public Policy Research and Analysis, 2002Africa's capacity to negotiate at the international level within organisations like the WTO has been greatly improved since Uruguay.DocumentImplications of the Doha Declaration on the TRIPS Agreement and public health
Essential Drugs and Medicine Policy, WHO, 2002The special declaration on issues relating to the Agreement on Trade-Related Aspects of Intellectual Property (TRIPS) represents an unprecedented step for the World Trade Organisation (WTO), but what are its implications?DocumentHealth (and IPRs)
Commission on Intellectual Property Rights, 2002It is feared that stronger patent protection is likely to increase the costs of medicines and reduce the ability of the poorest developing countries to improve public health conditions among their populations. Yet for pharmaceutical companies, patent protection gives them incentives to conduct research and development into new drugs.DocumentThe Doha agenda and intellectual property rights
Asian Development Bank Institute, 2002This paper reviews the possible outcomes of declarations made at the WTO Ministerial in Doha concerning the TRIPS agreement.DocumentCan 'the spirit of Doha' be kept alive?
SciDev.Net, 2003Background and commentary from SciDev.Net on the circumstances leading up to the failure of the TRIPS Council to reach agreement on access to generic drugs for developing countries by the deadline set in the "Doha Declaration".Dickson places the blame for this failure firmly in the hands of the pharmaceutical industry who sought sharp restrictions based on the scope of diseases covered and theDocumentThe FTAA, access to HIV/AIDS treatment, and human rights
Human Rights Watch, 2002This briefing paper begins by giving an outline of the WTO’s Trade Related Aspects of Intellectual Property Agreement (TRIPS) and of the Doha declaration by WTO members, which states that countries can bypass patents in medical emergencies.The paper argues that countries in the Free Trade Area of the Americas (FTAA) should resist pressure from the Office of the United States Trade RepresentativDocumentAmended patents act and access to medicines after Doha
International Environmental Law Research Centre, 2002This article examines the ammended India Patents Act which passed into law shortly after the Doha declaration on TRIPS and access to medicines.DocumentIssues linked to Convention on Biological Diversity in the WTO negotiations implementing Doha mandates.
Center for International Environmental Law, 2002This document analyses the content of TRIPS and CBD related mandates contained in the Ministerial texts approved at Doha. It aims at providing developing countries with suggestions for common action in the relevant WTO bodies.DocumentAnthrax, Drug Transnationals, and TRIPs
Foreign Policy in Focus, 2002Opinion piece from the Director of the Public Interest Research Centre in India which looks at TRIPS and the Doha declaration and draws inferences from the recent anthrax crisis in the US.Among the points the author makes are that:By sacrificing the public health concern of its own citizens to protect the private interests of drug TNCs, the U.S.DocumentWTO TRIPS agreement and its implications for access to medicines in developing countries
Commission on Intellectual Property Rights, 2002This detailed issue briefing examines TRIPS in light of the Doha Declaration which mandates that TRIPS be interpreted in a manner that supports public health interests and promotes access to medicines.The study accepts the consensus of experts that developing countries should make use of policy options such as compulsory licensing and parallel importation to increase the supply of low-price medPages